Liu, Zezhong
Zhou, Jie
Xu, Wei
Deng, Wei
Wang, Yanqun
Wang, Meiyu
Wang, Qian
Hsieh, Ming
Dong, Jingming
Wang, Xinling
Huang, Weijin http://orcid.org/0000-0002-4246-8889
Xing, Lixiao
He, Miaoling
Tao, Chunlin
Xie, Youhua http://orcid.org/0000-0002-2416-7708
Zhang, Yilong
Wang, Youchun http://orcid.org/0000-0001-9769-5141
Zhao, Jincun http://orcid.org/0000-0003-2515-5589
Yuan, Zhenghong http://orcid.org/0000-0003-0268-4891
Qin, Chuan http://orcid.org/0000-0002-6261-1232
Jiang, Shibo http://orcid.org/0000-0001-8283-7135
Funding for this research was provided by:
National Natural Science Foundation of China (81822045, 82041036, 82041025, 81630090)
Article History
Received: 15 November 2021
Accepted: 3 January 2022
First Online: 19 January 2022
Competing interests
: L.L., S.J., Z.L., M.H., Y.Z., J.Z., Q.W., and W.X. filed a patent application for the STING agonist. The other authors have no conflicts of interest to declare.